Evidence map›Paper›PMID 24451844›Full record

ArticleToxins2014

Active immunity induced by passive IgG post-exposure protection against ricin.

Charles Chen Hu, Junfei Yin, Damon Chau, John W Cherwonogrodzky, Wei-Gang Hu

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Charles Chen HuDefence Research and Development Canada-Suffield, Box 4000, Station Main, Medicine Hat, AB T1A 8K6, Canada. c.hu@mail.utoronto.ca.
Junfei YinDefence Research and Development Canada-Suffield, Box 4000, Station Main, Medicine Hat, AB T1A 8K6, Canada. jfyin78@gmail.com.
Damon ChauDefence Research and Development Canada-Suffield, Box 4000, Station Main, Medicine Hat, AB T1A 8K6, Canada. damon.chau@drdc-rddc.gc.ca.
John W CherwonogrodzkyDefence Research and Development Canada-Suffield, Box 4000, Station Main, Medicine Hat, AB T1A 8K6, Canada. john.cherwonogrodzky@drdc-rddc.gc.ca.
Wei-Gang HuDefence Research and Development Canada-Suffield, Box 4000, Station Main, Medicine Hat, AB T1A 8K6, Canada. wei-gang.hu@drdc-rddc.gc.ca.
Defence Research and Development Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic antibodies can confer an instant protection against biothreat agents when administered. In this study, intact IgG and F(ab')2 from goat anti-ricin hyperimmune sera were compared for the protection against lethal ricin mediated intoxication. Similar ricin-binding affinities and neutralizing activities in vitro were observed between IgG and F(ab')2 when compared at the same molar concentration. In a murine ricin intoxication model, both IgG and F(ab')2 could rescue 100% of the mice by one dose (3 nmol) administration of antibodies 1 hour after 5 × LD50 ricin challenge. Nine days later, when the rescued mice received a second ricin challenge (5 × LD50), only the IgG-treated mice survived; the F(ab')2-treated mice did not. The experimental design excluded the possibility of residual goat IgG responsible for the protection against the second ricin challenge. Results confirmed that the active immunity against ricin in mice was induced quickly following the passive delivery of a single dose of goat IgG post-exposure. Furthermore, it was demonstrated that the induced active immunity against ricin in mice lasted at least 5 months. Therefore, passive IgG therapy not only provides immediate protection to the victim after ricin exposure, but also elicits an active immunity against ricin that subsequently results in long term protection.

Indexed as

Immunity, ActiveAdministration, OralAnimalsEnzyme-Linked Immunosorbent AssayFemaleGoatsImmune SeraImmunoglobulin Fab FragmentsImmunoglobulin GMiceMice, Inbred BALB CRicinImmune SeraImmunoglobulin Fab FragmentsImmunoglobulin GRicin

Identifiers

PMID24451844
PMCPMC3920268
OpenAlexW2140795039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.